BV
Bhavnagri Veer
Conseiller Général
BoardM
Insider track record
Board DirectorNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by Bhavnagri Veer, Conseiller Général. Insider active across 2 companies, notably Allogene Therapeutics, Inc.. Cumulatively, 12 reports have been logged. Split: 0 buy · 4 sells. Total volume traded: €140k. History available since 17 May 2021. The latest transaction was filed on 14 March 2023 (Retenue fiscale). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Bhavnagri Veer
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations12 total
23,628 shares@ US$5.6737.7% of flowCommon StockSEC:0001593968-23-000491:0
3,000 shares@ US$6.855.8% of flowCommon StockSEC:0001593968-23-000317:0
3,000 shares@ US$7.045.9% of flowCommon StockSEC:0001593968-23-000168:0
5,602 shares@ US$7.530611.9% of flowCommon StockSEC:0001593968-22-001742:0
175,438 shares0Common StockSEC:0001214659-22-004370:0
8,849 shares@ US$7.68020.0090% mcap48.4% of flowCommon StockSEC:0001214659-22-004086:0
5,000 shares@ US$2.273.0% of flowCommon StockSEC:0001214659-21-009625:0
5,000 shares@ US$2.273.0% of flowCommon StockSEC:0001214659-21-008761:0
5,000 shares@ US$2.273.0% of flowCommon StockSEC:0001214659-21-007588:0
5,000 shares@ US$2.272.9% of flowCommon StockSEC:0001214659-21-006631:0
5,000 shares@ US$2.272.9% of flowCommon StockSEC:0001214659-21-005767:0
5,000 shares@ US$2.272.9% of flowCommon StockSEC:0001214659-21-005621:0
About Bhavnagri Veer
Veer Bhavnagri is General Counsel at Allogene Therapeutics, Inc. He is responsible for the company's legal affairs and compliance. Veer plays a key role in managing legal risks and protecting the company's interests. His expertise in business law is essential for navigating the complex regulatory landscape of the industry.